Seelos Therapeutics Inc (SEEL)
0.75
+0.03
(+4.17%)
USD |
OTCM |
Nov 15, 10:16
Seelos Therapeutics Cash and Short Term Investments (Quarterly): 0.294M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.294M |
| March 31, 2024 | 0.524M |
| December 31, 2023 | 2.996M |
| September 30, 2023 | 2.584M |
| June 30, 2023 | 5.843M |
| March 31, 2023 | 14.06M |
| December 31, 2022 | 15.53M |
| September 30, 2022 | 30.51M |
| June 30, 2022 | 41.25M |
| March 31, 2022 | 61.77M |
| December 31, 2021 | 78.73M |
| September 30, 2021 | 76.83M |
| June 30, 2021 | 87.20M |
| March 31, 2021 | 38.69M |
| December 31, 2020 | 15.66M |
| September 30, 2020 | 8.054M |
| June 30, 2020 | 5.854M |
| March 31, 2020 | 12.69M |
| December 31, 2019 | 10.26M |
| September 30, 2019 | 15.32M |
| June 30, 2019 | 9.728M |
| March 31, 2019 | 11.29M |
| December 31, 2018 | 3.579M |
| September 30, 2018 | 5.283M |
| June 30, 2018 | 6.836M |
| Date | Value |
|---|---|
| March 31, 2018 | 5.678M |
| December 31, 2017 | 6.331M |
| September 30, 2017 | 8.463M |
| June 30, 2017 | 7.821M |
| March 31, 2017 | 3.762M |
| December 31, 2016 | 2.087M |
| September 30, 2016 | 5.614M |
| June 30, 2016 | 2.723M |
| March 31, 2016 | 6.907M |
| December 31, 2015 | 3.887M |
| September 30, 2015 | 5.809M |
| June 30, 2015 | 7.433M |
| March 31, 2015 | 16.16M |
| December 31, 2014 | 11.40M |
| September 30, 2014 | 16.11M |
| June 30, 2014 | 17.42M |
| March 31, 2014 | 22.49M |
| December 31, 2013 | 21.40M |
| September 30, 2013 | 20.62M |
| June 30, 2013 | 24.76M |
| March 31, 2013 | 14.10M |
| December 31, 2012 | 15.13M |
| September 30, 2012 | 16.86M |
| June 30, 2012 | 17.94M |
| March 31, 2012 | 21.53M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.294M
Minimum
Jun 2024
87.20M
Maximum
Jun 2021
26.81M
Average
14.06M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| 180 Life Sciences Corp | 1.146M |
| Cassava Sciences Inc | 148.98M |
| Cara Therapeutics Inc | 56.62M |
| Citius Pharmaceuticals Inc | 17.91M |
| Moleculin Biotech Inc | 9.405M |